An Indian RCT shows that a technology-based cardiac rehabilitation programme designed for women dramatically improved MacNew quality of life, functional capacity, and heart-healthy behaviours — addressing a long-standing global equity gap in cardiac rehabilitation.
A new multicentre study from Cyprus shows that patients undergoing coronary artery bypass grafting experience an initial dip in quality of life before climbing well above their preoperative baseline by six months — with the MacNew capturing the journey at every step.
A pilot randomized controlled trial shows that a structured four-week prehabilitation programme for frail patients awaiting cardiac surgery delivers large improvements in functional capacity, frailty reversal, and MacNew quality of life — sustained months after discharge.
A large Cleveland Clinic study of 563 patients shows that whichever surgical approach patients receive for degenerative mitral regurgitation, quality of life returns to baseline within six months — with the MacNew social domain providing key insight that PROMIS-10 alone could not.
A groundbreaking randomized trial sheds new light on patient well-being, economics, and the essential role of patient-reported outcomes, measured using the MacNew Heart Disease questionnaire. In a newly published randomized controlled trial by Bosserdt et al. (2025) in European Radiology, researchers investigated the cost-utility of
Recovering from acute coronary syndrome (ACS) can feel overwhelming. Patients often grapple with uncertainties about managing their health and improving their daily lives. Fortunately, targeted education can dramatically enhance their recovery journey—and the MacNew Heart Disease Health-related Quality of Life Questionnaire has been crucial in
The MacNew Quality of Life questionnaire is a world-class research tool, demonstrated through its pivotal role in the study “Effectiveness of Tertiary Prevention on Quality of Life and Risk Factor Control in Patients with Ischemic Coronary Heart Disease,” by Rosalía Fernández Coronado and Adriel Olórtegui
We’re pleased to announce that the MacNew is now available in Tamil, catering to the language preferences of over 80 million Tamil speakers worldwide. This long-awaited update enhances accessibility and enables the exploration of the quality of life for individuals dealing with heart disease and
The MacNew is the leading patient-reported outcome measure for heart disease world wide. Recently we added the Bulgarian version of the MacNew to the portfolio. This extends the number of available languages for the MacNew to 46. The full list of available language versions can be
The MacNew continues to be the leading patient-reported outcome measure for heart disease worldwide. The Asian-Pacific focus of MacNew is constantly growing with three additional language versions now available: Kannada (India), Malayalam (India) and Indonesian (Indonesia). Kannada and Malayalam are spoken by over 100 million people